PE20020373A1 - Sistemas saborizantes para composiciones farmaceuticas y metodos para hacer dichas composiciones - Google Patents

Sistemas saborizantes para composiciones farmaceuticas y metodos para hacer dichas composiciones

Info

Publication number: PE20020373A1
Authority: PE; Peru
Prior art keywords: flavor; compositions; lopinavir; flavoring; water
Prior art date: 2000-09-05

Application number

PE2001000889A

Other languages

English (en)

Spanish (es)

Inventor

Laman Alani

Donald P Gauwitz

John M Lipari

Kennan C Marsh

Vanik D Petrossian

Richard H Whelan

Soumojeet Ghosh

Dilip Kaul

Original Assignee

Abbott Lab

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-09-05

Filing date

2001-09-04

Publication date

2002-05-13

2001-09-04 Application filed by Abbott Lab filed Critical Abbott Lab

2002-05-13 Publication of PE20020373A1 publication Critical patent/PE20020373A1/es

Links

239000000203 mixture Substances 0.000 title abstract 3
239000008194 pharmaceutical composition Substances 0.000 title 1
DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 abstract 3
KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 abstract 3
LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 abstract 2
KJHKTHWMRKYKJE-SUGCFTRWSA-N Kaletra Chemical compound N1([C@@H](C(C)C)C(=O)N[C@H](C[C@H](O)[C@H](CC=2C=CC=CC=2)NC(=O)COC=2C(=CC=CC=2C)C)CC=2C=CC=CC=2)CCCNC1=O KJHKTHWMRKYKJE-SUGCFTRWSA-N 0.000 abstract 2
NCDNCNXCDXHOMX-UHFFFAOYSA-N Ritonavir Natural products C=1C=CC=CC=1CC(NC(=O)OCC=1SC=NC=1)C(O)CC(CC=1C=CC=CC=1)NC(=O)C(C(C)C)NC(=O)N(C)CC1=CSC(C(C)C)=N1 NCDNCNXCDXHOMX-UHFFFAOYSA-N 0.000 abstract 2
FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 abstract 2
235000009508 confectionery Nutrition 0.000 abstract 2
239000000796 flavoring agent Substances 0.000 abstract 2
235000019634 flavors Nutrition 0.000 abstract 2
239000007788 liquid Substances 0.000 abstract 2
229960004525 lopinavir Drugs 0.000 abstract 2
NCDNCNXCDXHOMX-XGKFQTDJSA-N ritonavir Chemical compound N([C@@H](C(C)C)C(=O)N[C@H](C[C@H](O)[C@H](CC=1C=CC=CC=1)NC(=O)OCC=1SC=NC=1)CC=1C=CC=CC=1)C(=O)N(C)CC1=CSC(C(C)C)=N1 NCDNCNXCDXHOMX-XGKFQTDJSA-N 0.000 abstract 2
229960000311 ritonavir Drugs 0.000 abstract 2
239000002904 solvent Substances 0.000 abstract 2
NOOLISFMXDJSKH-KXUCPTDWSA-N (-)-Menthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@H]1O NOOLISFMXDJSKH-KXUCPTDWSA-N 0.000 abstract 1
229920000742 Cotton Polymers 0.000 abstract 1
235000006679 Mentha X verticillata Nutrition 0.000 abstract 1
235000002899 Mentha suaveolens Nutrition 0.000 abstract 1
235000001636 Mentha x rotundifolia Nutrition 0.000 abstract 1
XLYOFNOQVPJJNP-PWCQTSIFSA-N Tritiated water Chemical compound [3H]O[3H] XLYOFNOQVPJJNP-PWCQTSIFSA-N 0.000 abstract 1
244000290333 Vanilla fragrans Species 0.000 abstract 1
235000009499 Vanilla fragrans Nutrition 0.000 abstract 1
235000012036 Vanilla tahitensis Nutrition 0.000 abstract 1
239000008186 active pharmaceutical agent Substances 0.000 abstract 1
150000001298 alcohols Chemical class 0.000 abstract 1
235000019636 bitter flavor Nutrition 0.000 abstract 1
239000004359 castor oil Substances 0.000 abstract 1
235000019438 castor oil Nutrition 0.000 abstract 1
235000003599 food sweetener Nutrition 0.000 abstract 1
ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 abstract 1
150000002334 glycols Chemical class 0.000 abstract 1
235000019534 high fructose corn syrup Nutrition 0.000 abstract 1
239000004615 ingredient Substances 0.000 abstract 1
239000003607 modifier Substances 0.000 abstract 1
239000003921 oil Substances 0.000 abstract 1
239000001267 polyvinylpyrrolidone Substances 0.000 abstract 1
235000013855 polyvinylpyrrolidone Nutrition 0.000 abstract 1
229920000036 polyvinylpyrrolidone Polymers 0.000 abstract 1
239000011780 sodium chloride Substances 0.000 abstract 1
239000001509 sodium citrate Substances 0.000 abstract 1
NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 abstract 1
239000003765 sweetening agent Substances 0.000 abstract 1
239000002562 thickening agent Substances 0.000 abstract 1
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/426—1,3-Thiazoles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/513—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim having oxo groups directly attached to the heterocyclic ring, e.g. cytosine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Chemical & Material Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Virology (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Chemical Kinetics & Catalysis (AREA)
Oncology (AREA)
Communicable Diseases (AREA)
Molecular Biology (AREA)
Tropical Medicine & Parasitology (AREA)
AIDS & HIV (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Fats And Perfumes (AREA)

PE2001000889A 2000-09-05 2001-09-04 Sistemas saborizantes para composiciones farmaceuticas y metodos para hacer dichas composiciones PE20020373A1 (es)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US65519200A	2000-09-05	2000-09-05

Publications (1)

Publication Number	Publication Date
PE20020373A1 true PE20020373A1 (es)	2002-05-13

Family

ID=24627898

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PE2001000889A PE20020373A1 (es)	2000-09-05	2001-09-04	Sistemas saborizantes para composiciones farmaceuticas y metodos para hacer dichas composiciones

Country Status (10)

Country	Link
EP (1)	EP1315487A2 (fr)
JP (1)	JP2004522698A (fr)
AR (1)	AR030715A1 (fr)
AU (1)	AU2001288695A1 (fr)
BR (1)	BR0108433A (fr)
CA (1)	CA2417258A1 (fr)
MX (1)	MXPA03001952A (fr)
PE (1)	PE20020373A1 (fr)
UY (1)	UY26925A1 (fr)
WO (1)	WO2002020057A2 (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US7364752B1 (en)	1999-11-12	2008-04-29	Abbott Laboratories	Solid dispersion pharamaceutical formulations
EP1175205B1 (fr)	1999-11-12	2006-06-14	Abbott Laboratories	Dispersion solide comrpenant ritonavir, fenofibrate ou griseofulvin
RU2005119299A (ru) *	2002-11-22	2005-11-20	Фирмениш Са (Ch)	Составы для ухода за полостью рта, маскирующие соленый вкус солей
US8025899B2 (en)	2003-08-28	2011-09-27	Abbott Laboratories	Solid pharmaceutical dosage form
GB2423711B (en) *	2005-10-24	2007-02-14	Fortune Apex Dev Ltd	Method for preparing a pharmaceutical composition with enhanced mucoadhesion
TW201340998A (zh) *	2012-02-29	2013-10-16	Takeda Pharmaceutical	經口劑
US8771651B2 (en) *	2012-09-10	2014-07-08	Johnson & Johnson Consumer Companies, Inc.	Mouth rinses and tooth sensitivity treatment compositions

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
IL111991A (en) *	1994-01-28	2000-07-26	Abbott Lab	Liquid pharmaceutical composition of HIV protease inhibitors in organic solvent
AU3146997A (en) *	1996-06-03	1998-01-05	Merck & Co., Inc.	Pediatric formulation for hiv protease inhibitors

2001
- 2001-09-04 MX MXPA03001952A patent/MXPA03001952A/es unknown
- 2001-09-04 AU AU2001288695A patent/AU2001288695A1/en not_active Abandoned
- 2001-09-04 AR ARP010104207A patent/AR030715A1/es unknown
- 2001-09-04 JP JP2002524540A patent/JP2004522698A/ja not_active Withdrawn
- 2001-09-04 UY UY26925A patent/UY26925A1/es not_active Application Discontinuation
- 2001-09-04 WO PCT/US2001/027415 patent/WO2002020057A2/fr not_active Ceased
- 2001-09-04 EP EP01968449A patent/EP1315487A2/fr not_active Withdrawn
- 2001-09-04 CA CA002417258A patent/CA2417258A1/fr not_active Abandoned
- 2001-09-04 PE PE2001000889A patent/PE20020373A1/es not_active Application Discontinuation
- 2001-09-04 BR BRPI0108433-0A patent/BR0108433A/pt not_active IP Right Cessation

Also Published As

Publication number	Publication date
MXPA03001952A (es)	2003-09-10
EP1315487A2 (fr)	2003-06-04
JP2004522698A (ja)	2004-07-29
UY26925A1 (es)	2002-04-26
AR030715A1 (es)	2003-09-03
AU2001288695A1 (en)	2002-03-22
WO2002020057A2 (fr)	2002-03-14
CA2417258A1 (fr)	2002-03-14
WO2002020057A3 (fr)	2002-05-10
BR0108433A (pt)	2006-06-06

Legal Events

Date	Code	Title	Description
2003-08-28	FX	Voluntary withdrawal

Publication	Publication Date	Title
EP2735305B1 (fr)	2021-09-01	Préparations pharmaceutiques liquides stabilisées
PE20020373A1 (es)	2002-05-13	Sistemas saborizantes para composiciones farmaceuticas y metodos para hacer dichas composiciones
EP1543826B1 (fr)	2008-09-03	Solution aqueous concentree de ambroxol
PE20030545A1 (es)	2003-06-19	Formulaciones de jarabe de ribavirina
NO950134L (no)	1995-09-04	Formuleringer for oralt administrerte farmasöytiske midler
EP0315332B1 (fr)	1992-04-15	Compositions antitussives liquides contenant du phénol
JPH10502616A (ja)	1998-03-10	Ｄｘ−５２−１化合物の安定化法及びその凍結乾燥組成物
JP2003128583A (ja)	2003-05-08	清涼化組成物
US7429390B2 (en)	2008-09-30	Stable pharmaceutical compositions, processes for making the same and methods of their use
ES2310550T3 (es)	2009-01-16	Preparacion liquida acuosa de pranoprofeno.
US6194462B1 (en)	2001-02-27	Pharmaceutical preparation containing nimesulide for oral administration
US5874450A (en)	1999-02-23	Intranasal formulations for promoting sleep and method of using the same
CN114555085B (zh)	2024-12-27	包含溶栓肽-四氢异喹啉缀合物的药物组合物
CA1253160A (fr)	1989-04-25	Sels pharmaceutiques de 4'-(9-acridinylamino) methanesulfone-manisidide
EP3893865B1 (fr)	2026-03-25	Stick packs de diclofénac prêts à l'emploi
US4406888A (en)	1983-09-27	Aqueous micellar solutions of levonantradol and N-methyllevonantradol and lyophilic forms thereof for reconstitution
US6660743B1 (en)	2003-12-09	Therapeutic aqueous composition containing a hexahydro-5-pyrimidinamine compound and a polyalkoxylated fatty alcohol
JPH1135489A (ja)	1999-02-09	ポリオキシエチレン硬化ヒマシ油類の分解を防止した液剤
ES2238418T3 (es)	2005-09-01	Solucion acuosa estable de desoxifructosazina.
JP3990728B2 (ja)	2007-10-17	Ｎ−［４−オキソ−２−（１ｈ−テトラゾール−５−イル）−４ｈ−１−ベンゾピラン−８−イル］−４−（４−フェニルブトキシ）ベンズアミドの塩
JPH0733666A (ja)	1995-02-03	インドロカルバゾール誘導体の安定化法
JP2003055247A (ja)	2003-02-26	内服用液剤
JP2007008852A (ja)	2007-01-18	プラバスタチンを含有する水性製剤の安定化方法
ES2356828T3 (es)	2011-04-13	Preparados para gotas que comprenden dimentindeno.
GB1397893A (en)	1975-06-18	Pharmaceutical compositions